These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9570192)

  • 21. Effect of long-term hormone replacement therapy on coronary endothelial function in postmenopausal women.
    Halligan SC; Murtagh B; Lennon RJ; Pumper GM; Mathew V; Higano ST; Lerman A
    Mayo Clin Proc; 2004 Dec; 79(12):1514-20. PubMed ID: 15595335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of medroxyprogesterone acetate on endothelium-dependent vasodilation in postmenopausal women receiving estrogen.
    Wakatsuki A; Okatani Y; Ikenoue N; Fukaya T
    Circulation; 2001 Oct; 104(15):1773-8. PubMed ID: 11591613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy.
    Herrington DM; Braden GA; Williams JK; Morgan TM
    Am J Cardiol; 1994 May; 73(13):951-2. PubMed ID: 8184850
    [No Abstract]   [Full Text] [Related]  

  • 24. Orally and transdermally replaced estradiol improves endothelial function equally in middle-aged women after surgical menopause.
    Zegura B; Keber I; Sebestjen M; Borko E
    Am J Obstet Gynecol; 2003 May; 188(5):1291-6. PubMed ID: 12748500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Basal leg blood flow in healthy women is related to age and hormone replacement therapy status.
    Moreau KL; Donato AJ; Tanaka H; Jones PP; Gates PE; Seals DR
    J Physiol; 2003 Feb; 547(Pt 1):309-16. PubMed ID: 12562958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of hormone replacement therapy on nitric oxide bioactivity and monocyte chemoattractant protein-1 levels.
    Koh KK; Son JW; Ahn JY; Lee SK; Hwang HY; Kim DS; Jin DK; Ahn TH; Shin EK
    Int J Cardiol; 2001 Nov; 81(1):43-50. PubMed ID: 11690664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exercise as an alternative to oral estrogen for amelioration of endothelial dysfunction in postmenopausal women.
    Harvey PJ; Picton PE; Su WS; Morris BL; Notarius CF; Floras JS
    Am Heart J; 2005 Feb; 149(2):291-7. PubMed ID: 15846267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transdermal estrogen replacement therapy and vasomotor response.
    Kashiwagi M; Seino Y; Tsukamoto H; Takano T; Kaseki H
    Jpn Heart J; 2001 May; 42(3):307-15. PubMed ID: 11605769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women.
    Sherwood A; Bower JK; McFetridge-Durdle J; Blumenthal JA; Newby LK; Hinderliter AL
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1782-7. PubMed ID: 17541023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of short-term estrogen therapy on endothelial function: a double-blinded, randomized, controlled trial.
    Hurtado R; Celani M; Geber S
    Climacteric; 2016 Oct; 19(5):448-51. PubMed ID: 27427235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of a sequential combination of estradiol valerate and cyproterone acetate on the functional properties of the arterial wall in menopausal women].
    Mares P; Dauzat M; Abramovici Y; Deklunder G; Body G; Crepin G; Denis A; Favier M
    Gynecol Obstet Fertil; 2000; 28(7-8):509-17. PubMed ID: 10996962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women.
    Simon J; Klaiber E; Wiita B; Bowen A; Yang HM
    Menopause; 1999; 6(2):138-46. PubMed ID: 10374221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormone therapy and antioxidant vitamins do not improve endothelial vasodilator function in postmenopausal women with established coronary artery disease: a substudy of the Women's Angiographic Vitamin and Estrogen (WAVE) trial.
    Kelemen M; Vaidya D; Waters DD; Howard BV; Cobb F; Younes N; Tripputti M; Ouyang P
    Atherosclerosis; 2005 Mar; 179(1):193-200. PubMed ID: 15721027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study.
    Gebara OC; Mittleman MA; Sutherland P; Lipinska I; Matheney T; Xu P; Welty FK; Wilson PW; Levy D; Muller JE
    Circulation; 1995 Apr; 91(7):1952-8. PubMed ID: 7895352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study.
    Santoro N; Allshouse A; Neal-Perry G; Pal L; Lobo RA; Naftolin F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Dowling NM; Dunn M; Gleason CE; Hodis HN; Isaac B; Magnani M; Manson JE; Miller VM; Taylor HS; Wharton W; Wolff E; Zepeda V; Harman SM
    Menopause; 2017 Mar; 24(3):238-246. PubMed ID: 27779568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral estrogen replacement therapy increases forearm reactive hyperemia accompanied by increases in serum levels of nitric oxide in postmenopausal women.
    Sanada M; Higashi Y; Nakagawa K; Sasaki S; Kodama I; Sakashita T; Tsuda M; Ohama K
    Gynecol Endocrinol; 2001 Apr; 15(2):150-7. PubMed ID: 11379012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women.
    Gilligan DM; Quyyumi AA; Cannon RO
    Circulation; 1994 Jun; 89(6):2545-51. PubMed ID: 8205663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term estrogen replacement therapy is associated with improved exercise capacity in postmenopausal women without known coronary artery disease.
    Redberg RF; Nishino M; McElhinney DB; Dae MW; Botvinick EH
    Am Heart J; 2000 Apr; 139(4):739-44. PubMed ID: 10740161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study.
    Perera M; Sattar N; Petrie JR; Hillier C; Small M; Connell JM; Lowe GD; Lumsden MA
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1140-3. PubMed ID: 11238498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.